Can Humira Patent-Life Be Extended?

[Anonymous]

From WSJ 2/26/2013...

AbbVie is suing the U.S. Patent and Trademark Office to extend protections for a salt-and-alcohol solution used in Humira, a potential bulwark after its main patent lapses.

"It's going to be a difficult market for new competitors to enter," said AbbVie Chief Executive Richard Gonzalez. Because of the complexities of making biologic drugs, companies can also gain patents on manufacturing procedures and formulations—for instance, to extend shelf-life—that are unusual in the world of conventional drugs. Mr. Gonzalez pledged AbbVie would defend about 200 such patents for Humira.

 

[Anonymous]

And all of them will lose, look at our history of "vigorously defend our patents" not good...Abbvie, please bring something new, aquire someone/something, etc. Me too drugs with XL, XP, XR, etc after the name last a few years tops. New drugs, co promotions, etc will grow abbvie, not just sitting around with attorneys deciding how to fight generic competition......Thats how Pharma companies die......

 

[Anonymous]

And all of them will lose, look at our history of "vigorously defend our patents" not good...Abbvie, please bring something new, aquire someone/something, etc. Me too drugs with XL, XP, XR, etc after the name last a few years tops. New drugs, co promotions, etc will grow abbvie, not just sitting around with attorneys deciding how to fight generic competition......Thats how Pharma companies die......

Actually, all of them will NOT lose. And only a few need to win. Abbott, and now AbbVie has a long and storied history of increasing shareholder value with very few new, novel products that were not purchased from someone else,or simple product line extensions. The lawyers that cost us a small fortune, make us a huge fortune by delaying the release of generic drugs, including biologics. Humira will continue to drive our profits and patient recoveries for decades to come.
LAWYERS, YAY!

 

[Anonymous]

Actually, all of them will NOT lose. And only a few need to win. Abbott, and now AbbVie has a long and storied history of increasing shareholder value with very few new, novel products that were not purchased from someone else,or simple product line extensions. The lawyers that cost us a small fortune, make us a huge fortune by delaying the release of generic drugs, including biologics. Humira will continue to drive our profits and patient recoveries for decades to come.
LAWYERS, YAY!

The companies gearing up to make a biosimular Humira are not the run of the mill generic companies, but other large pharma and biotechs. They too have great lawyers and the fight will be much harder. There is way too much money to made in the anti-TNF market. Those that think the Humira gravy train will last forever are only fooling themselves.

 

[Anonymous]

Actually, all of them will NOT lose. And only a few need to win. Abbott, and now AbbVie has a long and storied history of increasing shareholder value with very few new, novel products that were not purchased from someone else,or simple product line extensions. The lawyers that cost us a small fortune, make us a huge fortune by delaying the release of generic drugs, including biologics. Humira will continue to drive our profits and patient recoveries for decades to come.
LAWYERS, YAY!

What about our great scientists? I heard recently it was discovered that if you put Humira on your earlobe it will cure the flu, auditory cancer, STDs, and terets (sp?). It happened by accident when a Principal scientist at a site with the above disorders, wiped his ear when delivering a dose. Yes, and Kudos for our lawyers for all that great contract language that gives ownership to this fantabulous discovery. It is almost as good as Snake Oil.

 

[Anonymous]

The companies gearing up to make a biosimular Humira are not the run of the mill generic companies, but other large pharma and biotechs. They too have great lawyers and the fight will be much harder. There is way too much money to made in the anti-TNF market. Those that think the Humira gravy train will last forever are only fooling themselves.

Yes, this isnt Teva wanting to market generic tricor, these are true competitors with competitive products. Humira will steadily lose share as more drugs enter the market, Humira may have 3 years tops to rake it in so to speak. Abbvie was either split off to do one of two things: A) sell abbvie to another company. B) actually grow the company with aquisitions and bring new drugs to market. There is no other arguments its one or the other. They did by the way release a huge amount of baggage when layoffs hit and those who were with abbott for 25 years or more get a pittance in pension and severance ala Hospira...Good luck to all...

 

[Anonymous]

The companies gearing up to make a biosimular Humira are not the run of the mill generic companies, but other large pharma and biotechs. They too have great lawyers and the fight will be much harder. There is way too much money to made in the anti-TNF market. Those that think the Humira gravy train will last forever are only fooling themselves.

This is a great point. Amgen, for instance, is already a biologics manufacturer so it only makes sense that they could make a biosimilar.

 

[Anonymous]

Abbvie unless it brings new drugs to market, aquires under promoted drugs, etc will die a quick death. I mean how many times have We seen the guy in Holland with Parkisons and the Duodopa pump?? With nothing else coming and with patent expirations on ALL of our current drugs, this is just like the titanic. People are looking for life boats and there arent any. Cardio Care is on life support and paying out huge bonus dollars to squeeze the last dime out of our branded agents before they lose patent later this year. So, what advice to We get?? Post for other positions. Sure, go take a look. Slim pickins; in many cases there are no sales positions available within 300 miles from a home base. So can Humira weather the patent storm coming? Most likely , No.

 

[Anonymous]

Abbvie unless it brings new drugs to market, aquires under promoted drugs, etc will die a quick death. I mean how many times have We seen the guy in Holland with Parkisons and the Duodopa pump?? With nothing else coming and with patent expirations on ALL of our current drugs, this is just like the titanic. People are looking for life boats and there arent any. Cardio Care is on life support and paying out huge bonus dollars to squeeze the last dime out of our branded agents before they lose patent later this year. So, what advice to We get?? Post for other positions. Sure, go take a look. Slim pickins; in many cases there are no sales positions available within 300 miles from a home base. So can Humira weather the patent storm coming? Most likely , No.

You will all be fine. There are many options for the future that will be coming your way like welfare, voting for democrats, living in the inner city. You'll all be fine.